Probably the virus was here much before, given that it was found in Brazil in early November. There was no stopping it.
Nobody, including Democratic governors, would have supported a lockdown in January or February. Monday-Morning Quarterbacking is way easier than playing the game on Sunday. All the people saying that Trump took too long to act, would be going for his throat if he had recommended a lockdown in January or February. Not to forget, he would only be able to recommend it, but the responsibility falls on the governors. I remember when Trump was insisting that New York needed a lockdown, Governor Cuomo said he'd consider it an act of civil war if Trump tried to impose it.
Correct, and the US jumped on the vaccine with, indeed, warp speed. On January 13 Moderna received the genetic sequence of the virus and they delivered the first batch of vaccine to start testing, 42 days later. The HHS granted to Moderna almost half a billion dollars to increase vaccine development and production, and gave grants to four other companies too (I know of AstraZeneca; I don't know what the other three are). I somehow suspect that this energetic and fast action to support private initiative in getting a vaccine would not have happened under a Democratic president.
Now, I'm growing a bit less optimistic regarding the vaccine.
AstraZeneca/Oxford have already started phase 3 since June. They are now the frontrunners. Sinovac, the Chinese one, is starting phase 3 on July 20th, and Sinopharm has already started theirs. Moderna is falling behind; once the frontrunner, now in 4th place (which is terrible for their investors). They were supposed to start phase 3 on July 10 but postponed "maybe" to the end of the month, apparently due to disagreements with the NIH regarding the design of the phase 3 trials (Moderna, a small start-up, has never pushed any vaccine or medication through phase 3, and some NIH officials are finding them inexperienced and not willing to listen to advice; apparently they finally did when they realized that the FDA wouldn't be going for approval if they didn't specify some safety details they had been vague about and the NIH advised them to include; redesigning the protocol is causing the delay).
I wanted Moderna to win the race because it's a 100% American company and they would attend to our internal market first. AstraZeneca is not so bad an option because they also got money from the Warp Speed initiative and promised, in exchange, to reserve 300 million doses to the American market. But of course, the two Chinese candidates will tend to their own huge population first.
Worse than Moderna's troubles which ultimately can be resolved, is the study that came out of Spain this week showing that only 5% of their population has antibodies against the SARS-CoV-2 (despite their huge outbreak) and some people who had them, retested negative for antibodies only 14 days after they had tested positive.
This means two things: one, antibodies seem short-lived so herd immunity is simply unachievable. Of course there is also T-cell memory but apparently T-cells were not forming enough memory of the virus in asymptomatic and mildly symptomatic patients. Two, it doesn't bode well for vaccines, unless they are repeatedly given, which throws out the calculation of how many doses are needed. If this vaccine needs to be given again, say, every 3 months, then 300 million doses can only cover 75 million Americans. Immunity might fade even before the booster dose.
I feel very discouraged today. If a vaccine fails I'll enter desperation mode, because eventually everybody will be exposed to this virus and when I do, I'm quite sure I won't survive it, given my underlying medical conditions.